BioSpace News Archive

Business

Novanta Announces Financial Results for the Second Quarter 2018

Second Quarter 2018 GAAP Revenue of $150.4 million, up 26% year over year

August 8, 2018
·
57 min read
Pharm Country

Realm Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference

Realm Therapeutics plc announces that Alex Martin, CEO, will be presenting at the 2018 Wedbush PacGrow Healthcare Conference, on Tuesday, August 14, 2018 at 4:15 p.m. ET at the Parker New York.

August 8, 2018
·
1 min read
Deals

AcelRx Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

AcelRx Pharmaceuticals, Inc. announced that the underwriters of its previously announced underwritten public offering have exercised in full their option to purchase an additional 1,090,909 shares of AcelRx’s common stock.

August 8, 2018
·
2 min read
Business

Context Therapeutics Signs Strategic Research Collaborations for Apristor® (onapristone extended release) With Key Academic Leaders in the Progesterone Receptor (PR) and Breast Cancer Fields

Context Therapeutics today announces it has signed multiple research collaborations to further understand the role of progesterone receptor (PR) signaling.

August 8, 2018
·
4 min read
Business

Concordia International Corp. Announces Second Quarter 2018 Results

Second quarter 2018 revenue of approximately $139 million

August 8, 2018
·
39 min read
Policy

QUANTM Irradiation System™ Earns CE Mark Approval

First-in-class, advanced technology enables production of high-value radioisotopes on medical cyclotrons.

August 8, 2018
·
2 min read
FDA

Alector Receives Orphan Drug Designation from the U.S. FDA for AL001 for the Treatment of Frontotemporal Dementia

AL001 is a human recombinant monoclonal antibody, for the treatment of all patients with frontotemporal dementia.

August 8, 2018
·
2 min read
Business

Rocket Pharmaceuticals Reports Second Quarter 2018 Financial Results and Operational Highlights

Achieved Regulatory Designations for Fanconi Anemia (FA) in the U.S. and Europe; Registrational Trial on Track for 2019

August 8, 2018
·
10 min read
Business

Horizon Pharma plc Reports Record Quarterly Net Sales for Orphan and Rheumatology Segment; Increases Full-Year 2018 Adjusted EBITDA Guidance; Implements New Company Operating Structure to Enhance Focus on Rare Diseases

-- Record Quarterly Orphan and Rheumatology Segment Net Sales of $201.7 Million Increased 17 Percent; Represented 67 Percent of Total Company Net Sales --

August 8, 2018
·
44 min read
Business

Rockwell Medical Appoints New Chief Executive Officer

Stuart Paul Brings Significant Healthcare Experience

August 8, 2018
·
7 min read